Evidence map›Paper›PMID 41079104›Full record

SynthesisFrontiers in oncology2025

Scientometric analysis of glioblastoma and blood-brain barrier research (1995-2024): evolving trends and therapeutic challenges.

Xuan-Hao Pan, Nan Wang, Yi-Chun He, Jing Su, Yu-Fei Gao

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xuan-Hao PanDepartment of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Nan WangDepartment of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Yi-Chun HeDepartment of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Jing SuDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.
Yu-Fei GaoDepartment of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glioblastoma (GBM) is one of the most aggressive neurogenic tumors. Despite advances in treatment, the presence of the blood-brain barrier (BBB) continues to pose significant challenges to effective therapeutic delivery. However, to date, no comprehensive bibliometric analysis has systematically evaluated the relationship between GBM and the BBB over the past three decades. Objective: This study provides an overview of research progress on GBM and the BBB, with emphasis on structural and functional changes of the BBB. It also identifies current research hotspots, predicts emerging trends, and offers insights for future investigations. Method: Literature from the past 30 years was retrieved from the Web of Science Core Collection and PubMed. Bibliometric analysis was performed using the R programming language, and data visualization was conducted with VOSviewer, CiteSpace, and Tableau. Result: Since 2015, publication output and academic influence in this field have increased exponentially. The United States leads in both publication volume and citation count, and engages in extensive international collaborations. Conclusion: This study offers a comprehensive overview of GBM-BBB research trends over the past 30 years. It advances the understanding of their interplay and provides theoretical guidance for overcoming the BBB and improving GBM outcomes.

Indexed as

blood-brain barrierdrug deliveryglioblastomaresearch trendsscientometric analysis

Identifiers

PMID41079104
PMCPMC12507556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.